Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Schering Canada and University of Toronto collaborate on Alzheimer research

Jan. 30, 1997

Pilot trial of folic acid in stroke patients

Jan. 30, 1997

Cortex claims AMPA receptor modulators for CNS disorders

Jan. 30, 1997

New steroidal anesthetics from Akzo Nobel

Jan. 30, 1997

Preliminary analysis of pivotal trials on transdermal buspirone announced

Jan. 29, 1997

New ropinirole formulation described by SKB

Jan. 29, 1997

HOP-1 claimed by Signal for treatment of CNS disorders

Jan. 29, 1997

NAChR agonist SIB-1765F: Potential antiparkinsonian agent

Jan. 28, 1997

Enantiospecific synthesis of SP antagonist from RPR

Jan. 28, 1997

Novartis selects analgesic agent as clinical candidate

Jan. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...